|
1
|
Zhong M, Sun A, Xiao T, Yao G, Sang L,
Zheng X, Zhang J, Jin X, Xu L, Yang W, et al: A randomized,
single-blind, group sequential, active-controlled study to evaluate
the clinical efficacy and safety of α-lipoic acid for critically
Ill patients with coronavirus disease 2019 (COVID-19). Front Med
(Lausanne). 8(566609)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Danion F, Letscher-Bru V, Guitard J,
Sitbon K, Dellière S, Angoulvant A, Desoubeaux G, Botterel F,
Bellanger AP, Gargala G, et al: Coronavirus disease 2019-associated
Mucormycosis in France: A rare but deadly complication. Open Forum
Infect Dis. 9(ofab566)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics
of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Popov GT, Baymakova M, Vaseva V,
Kundurzhiev T and Mutafchiyski V: Clinical characteristics of
hospitalized patients with COVID-19 in Sofia, Bulgaria. Vector
Borne Zoonotic Dis. 20:910–915. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lechien JR, Chiesa-Estomba CM, Place S,
Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S,
et al: Clinical and epidemiological characteristics of 1420
European patients with mild-to-moderate coronavirus disease 2019. J
Intern Med. 288:335–344. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kim PS, Schildhouse RJ, Saint S, Bradley
SF, Chensue S, Houchens N and Gupta A: Vaccine breakthrough
infections in veterans hospitalized with coronavirus infectious
disease-2019: A case series. Am J Infect Control. 50:273–276.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ahmad Khidir K: Coronavirus disease 2019
vaccine hesitancy in the kurdistan region: A cross-sectional
national survey. Arch Razi Inst. 76:751–759. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zafari M, Rad MTS and Mohseni F:
Coronavirus disease 2019 (COVID-19) and pregnancy: A narrative
review. Curr Pediatr Rev. 18:97–102. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lima GRG, Albuquerque GMA, Amaral TLM and
Prado PRD: Nursing care to COVID-19 patients on hemodialysis and in
prone position: An experience report. Rev Esc Enferm USP.
55(e20210118)2021.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
10
|
Fonss Rasmussen L, Grode LB, Lange J,
Barat I and Gregersen M: Impact of transitional care interventions
on hospital readmissions in older medical patients: A systematic
review. BMJ Open. 11(e040057)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Borgen I, Romney MC, Redwood N, Delgado B,
Alea P, George BH, Puzziferro J and Shihabuddin L: From hospital to
home: An intensive transitional care management intervention for
patients with COVID-19. Popul Health Manag. 24:27–34.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sumikawa Y and Yamamoto-Mitani N:
Transitional care during COVID-19 pandemic in Japan: Calls for new
strategies to integrate traditional approaches with information and
communication technologies. Biosci Trends. 15:55–57.
2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang Z, Deng H, Ou C, Liang J, Wang Y,
Jiang M and Li S: Clinical symptoms, comorbidities and
complications in severe and non-severe patients with COVID-19: A
systematic review and meta-analysis without cases duplication.
Medicine (Baltimore). 99(e23327)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pamukcu B: Inflammation and thrombosis in
patients with COVID-19: A prothrombotic and inflammatory disease
caused by SARS coronavirus-2. Anatol J Cardiol. 24:224–234.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang Y, Zhang D, Du G, et al: Remdesivir
in adults with severe COVID-19: A randomised, double-blind,
placebo-controlled, multicentre trial. Lancet. 395:1569–1578.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang X, Li Y, Li H, Zhao Y, Ma D, Xie Z
and Sun J: Application of the OMAHA System in the education of
nursing students: A systematic review and narrative synthesis.
Nurse Educ Pract. 57(103221)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Stocker R, Tran T, Hammarberg K, Nguyen H,
Rowe H and Fisher J: Patient health questionnaire 9 (PHQ-9) and
general anxiety disorder 7 (GAD-7) data contributed by 13,829
respondents to a national survey about COVID-19 restrictions in
Australia. Psychiatry Res. 298(113792)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Obbarius A, van Maasakkers L, Baer L,
Clark DM, Crocker AG, de Beurs E, Emmelkamp PMG, Furukawa TA,
Hedman-Lagerlöf E, Kangas M, et al: Standardization of health
outcomes assessment for depression and anxiety: Recommendations
from the ICHOM depression and anxiety working group. Qual Life Res.
26:3211–3225. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Karahan I: The COVID-19 anxiety of
hospitalised patients in a palliative care unit. Int J Palliat
Nurs. 26(267)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bai Y, Lin CC, Lin CY, Chen JY, Chue CM
and Chou P: Survey of stress reactions among health care workers
involved with the SARS outbreak. Psychiatr Serv. 55:1055–1057.
2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Greco F, Altieri VM, Esperto F, Mirone V
and Scarpa RM: Impact of COVID-19 pandemic on health-related
quality of life in Uro-oncologic patients: What should we wait for?
Clin Genitourin Cancer. 19:e63–e68. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Graham BL, Brusasco V, Burgos F, Cooper
BG, Jensen R, Kendrick A, MacIntyre NR, Thompson BR and Wanger J:
2017 ERS/ATS standards for single-breath carbon monoxide uptake in
the lung. Eur Respir J. 49(1600016)2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chirico D, Davidson TW, Terada T, Scott K,
Keast ML, Reid RD, Pipe AL and Reed JL: Using the 6-min walk test
to monitor peak oxygen uptake response to cardiac rehabilitation in
patients with heart failure. J Cardiopulm Rehabil Prev. 40:378–382.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Perez-Gomez B, Pastor-Barriuso R,
Perez-Olmeda M, Hernán MA, Oteo-Iglesias J, Fernández de Larrea N,
Fernández-García A, Martín M, Fernández-Navarro P, Cruz I, et al:
ENE-COVID nationwide serosurvey served to characterize asymptomatic
infections and to develop a symptom-based risk score to predict
COVID-19. J Clin Epidemiol. 139:240–254. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Jia Y, Chen O, Xiao Z, Xiao J, Bian J and
Jia H: Nurses' ethical challenges caring for people with COVID-19:
A qualitative study. Nurs Ethics. 28:33–45. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tomidokoro D, Hayama H, Okazaki T, Hara H
and Hiroi Y: The effect of the COVID-19 pandemic on incidence and
characteristics of pulmonary embolism. Glob Health Med. 3:122–124.
2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ibnouf AO, Khalil MH, Khalid R, Elshibli
EM, Elsayed O and Fadl-Elmula I: Blood markers (lymphocyte
percentages, neutrophils, CRP and ESR) can help in prioritizing
rRT-PCR test for suspected COVID-19 patients in countries with
limited health resources. Pan Afr Med J. 37(331)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kerget B, Kerget F, Aksakal A, Askin S,
Saglam L and Akgun M: Evaluation of alpha defensin, IL-1 receptor
antagonist, and IL-18 levels in COVID-19 patients with macrophage
activation syndrome and acute respiratory distress syndrome. J Med
Virol. 93:2090–2098. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tang J, Lin J, Zhang E, Zhong M, Luo Y, Fu
Y and Yang Y: Serum IL-6 and procalcitonin are two promising novel
biomarkers for evaluating the severity of COVID-19 patients.
Medicine (Baltimore). 100(e26131)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Avdeev SN, Trushenko NV, Tsareva NA,
Yaroshetskiy AI, Merzhoeva ZM, Nuralieva GS, Nekludova GV, Chikina
SY, Gneusheva TY, Suvorova OA and Shmidt AE: Anti-IL-17 monoclonal
antibodies in hospitalized patients with severe COVID-19: A pilot
study. Cytokine. 146(155627)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Leija-Martinez JJ, Huang F,
Del-Rio-Navarro BE, Sanchéz-Muñoz F, Muñoz-Hernández O,
Giacoman-Martínez A, Hall-Mondragon MS and Espinosa-Velazquez D:
IL-17A and TNF-α as potential biomarkers for acute respiratory
distress syndrome and mortality in patients with obesity and
COVID-19. Med Hypotheses. 144(109935)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Guo J, Lin WW, Zucker JE, Nandakumar R,
Uhlemann AC, Wang S and Shivakoti R: Inflammation and mortality in
COVID-19 hospitalized patients with and without type 2 diabetes. J
Clin Endocrinol Metab. 107:e1961–e1968. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Shaku F, Ishiburo M, Miwa M and Maruoka S:
Mental Health Status before and during the COVID-19 pandemic in
patients first visiting a psychosomatic internal medicine clinic in
Tokyo, Japan. Int J Environ Res Public Health.
19(2488)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Loerinc LB, Scheel AM, Evans ST, Shabto
JM, O'Keefe GA and O'Keefe JB: Discharge characteristics and care
transitions of hospitalized patients with COVID-19. Healthc (Amst).
9(100512)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
McDonagh JE, Tattersall R, Clinch J, Swan
J, Foster HE and McCann L: Developmentally appropriate transitional
care during the Covid-19 pandemic for young people with
juvenile-onset rheumatic and musculoskeletal diseases: The
rationale for a position statement. Pediatr Rheumatol Online J.
19(136)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Adrielle Dos Santos L, Filho PGG, Silva
AMF, Santos JVG, Santos DS, Aquino MM, de Jesus RM, Almeida MLD, da
Silva JS, Altmann DM, et al: Recurrent COVID-19 including evidence
of reinfection and enhanced severity in thirty Brazilian healthcare
workers. J Infect. 82:399–406. 2021.PubMed/NCBI View Article : Google Scholar
|
